BEIJING — China’s latest export controls has rattled insiders of the critical minerals industry, and some are concerned that Beijing will leverage its global
Investor sentiment with respect to Palantir Technologies Inc. (NYSE:PLTR) has substantially improved after the company reported better-than-expected second quarter results and raised its guidance
Denali Therapeutics Inc. (NASDAQ:DNLI) is a clinical-stage biotech developing neurodegenerative disease therapies. The company’s main value driver is its brain delivery platform, which uses